Avantor, Inc.
Health
Performance
7.6
Risk
Sell
Buy
Curious about the Scores? Learn more.

Avantor, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

04.07.2026
Rock bottom. The fall’s complete, stability nowhere to be found.
01.07.2026
Danger zone. Balance sheet’s flashing red across the board.
09.06.2026
Off life support. Still risky, but slightly less scary.
AVTR
Avantor, Inc.
10.99
+3.10%
7.6
Sell
Buy
Avantor, Inc.

Avantor, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Avantor, Inc. do? Business model and key facts

Get the full picture of Avantor, Inc.: what it builds, where it operates, and how it makes money.

Avantor, Inc. Profile

Sector: Healthcare

Industry: Medical - Instruments & Supplies

Employees (FY): 13500

Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.

shop
Company facts
Emmanuel Ligner
CEO
13500
Employees worldwide
shop
Performance
-10.94%
Last 12 months
-70.17%
Last 5 years
shop
Growth
$6.55B
Revenue year
$-530,200,000
Net income
shop
Valuation
$7.56B
Market Cap
-14.69
Price/Earnings Ratio

Stocks related to Avantor, Inc.

Selected based on industry alignment and relative market positioning.

RGEN
Repligen Corporation
136.99
-5.84%
5.5
Sell
Buy
Repligen Corporation
ATR
AptarGroup, Inc.
128.91
-0.77%
4.9
Sell
Buy
AptarGroup, Inc.
BAX
Baxter International Inc.
22.21
+0.63%
5.8
Sell
Buy
Baxter International Inc.
TFX
Teleflex Incorporated
135.01
+0.73%
4.0
Sell
Buy
Teleflex Incorporated
BLCO
Bausch + Lomb Corporation
15.99
+0.06%
4.3
Sell
Buy
Bausch + Lomb Corporation

Events and news impacting Avantor, Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

Avantor, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.